IL147755A0 - Multi-dose erythropoietin formulations - Google Patents

Multi-dose erythropoietin formulations

Info

Publication number
IL147755A0
IL147755A0 IL14775500A IL14775500A IL147755A0 IL 147755 A0 IL147755 A0 IL 147755A0 IL 14775500 A IL14775500 A IL 14775500A IL 14775500 A IL14775500 A IL 14775500A IL 147755 A0 IL147755 A0 IL 147755A0
Authority
IL
Israel
Prior art keywords
formulations
dose erythropoietin
erythropoietin formulations
dose
phenoxyethanol
Prior art date
Application number
IL14775500A
Other languages
English (en)
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of IL147755A0 publication Critical patent/IL147755A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL14775500A 1999-07-22 2000-07-21 Multi-dose erythropoietin formulations IL147755A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19821699P 1999-07-22 1999-07-22
PCT/US2000/040446 WO2001007075A2 (en) 1999-07-22 2000-07-21 Multi-dose erythropoietin formulations

Publications (1)

Publication Number Publication Date
IL147755A0 true IL147755A0 (en) 2002-08-14

Family

ID=22732468

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14775500A IL147755A0 (en) 1999-07-22 2000-07-21 Multi-dose erythropoietin formulations
IL147755A IL147755A (en) 1999-07-22 2002-01-21 Multi-dose erythropoietin formulations with benzethonium chloride as a bacterial growth inhibitor

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147755A IL147755A (en) 1999-07-22 2002-01-21 Multi-dose erythropoietin formulations with benzethonium chloride as a bacterial growth inhibitor

Country Status (25)

Country Link
US (1) US7432360B2 (zh)
EP (1) EP1200115B9 (zh)
JP (1) JP2003517462A (zh)
KR (1) KR100693263B1 (zh)
CN (2) CN1371284A (zh)
AT (1) ATE304863T1 (zh)
AU (1) AU777397B2 (zh)
BR (1) BR0012667A (zh)
CA (1) CA2378945C (zh)
CZ (1) CZ302750B6 (zh)
DE (1) DE60022759T2 (zh)
DK (1) DK1200115T3 (zh)
EA (1) EA006220B1 (zh)
EE (1) EE200200037A (zh)
ES (1) ES2248110T3 (zh)
HK (1) HK1050318A1 (zh)
HR (1) HRP20020159B1 (zh)
HU (1) HUP0202246A3 (zh)
IL (2) IL147755A0 (zh)
NO (1) NO20020303L (zh)
NZ (1) NZ516735A (zh)
PL (1) PL202945B1 (zh)
RS (1) RS50355B (zh)
WO (1) WO2001007075A2 (zh)
ZA (1) ZA200200742B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020032534A (ko) 1999-07-22 2002-05-03 게리 디. 스트리트, 스티븐 엘. 네스비트 보존 제약 제형
ES2237574T5 (es) 2000-05-15 2017-08-09 F. Hoffmann-La Roche Ag Composición farmacéutica líquida que contiene un derivado de eritropoyetina
CN1960745A (zh) * 2004-03-26 2007-05-09 詹森药业有限公司 促红细胞生成素组合加药方案
US7772182B2 (en) 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
US8877234B2 (en) * 2005-02-03 2014-11-04 Clariant Finance (Bvi) Limited Preservatives
JP2011116752A (ja) * 2009-10-29 2011-06-16 Jcr Pharmaceuticals Co Ltd エリスロポエチン含有水性液剤
KR101805087B1 (ko) * 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형
AU2016341241B9 (en) * 2015-10-22 2021-11-18 Iltoo Pharma Pharmaceutical compositions of IL-2

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489837A (en) * 1968-07-11 1970-01-13 Leroy J Hyman Synergistic antiseptic composition consisting of 9-aminoacridine hydrochloride and benzethonium chloride
JPS6045849B2 (ja) 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
JPS6191131A (ja) * 1984-10-09 1986-05-09 Chugai Pharmaceut Co Ltd 医薬品の吸着防止方法および組成物
JPS6197229A (ja) 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPH0651637B2 (ja) * 1985-03-28 1994-07-06 エーザイ株式会社 ペプタイドの吸着防止組成物
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments
JP3249147B2 (ja) * 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
CA2050425A1 (en) * 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
JP2532025B2 (ja) * 1993-07-23 1996-09-11 株式会社林原生物化学研究所 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
WO1995033474A1 (fr) * 1994-06-03 1995-12-14 Tsumura & Co. Composition medicinale
WO1997026004A1 (en) * 1996-01-19 1997-07-24 Eli Lilly And Company Obesity protein formulations
CN1233963A (zh) * 1996-09-13 1999-11-03 有限会社最先端医学研究所 神经营养因子的眼科用组合物、视神经机能障碍治疗药和视神经机能障碍治疗方法
JPH1112193A (ja) * 1997-06-19 1999-01-19 Sankyo Co Ltd ヒトカルシトニン含有水溶液製剤
GB9726555D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Vaccine

Also Published As

Publication number Publication date
EP1200115A2 (en) 2002-05-02
CA2378945C (en) 2010-02-23
HUP0202246A3 (en) 2010-01-28
CN101091792A (zh) 2007-12-26
YU4702A (sh) 2005-06-10
WO2001007075A2 (en) 2001-02-01
CZ2002264A3 (cs) 2002-06-12
US20050267033A1 (en) 2005-12-01
HRP20020159B1 (en) 2007-08-31
WO2001007075A3 (en) 2001-10-04
CZ302750B6 (cs) 2011-10-19
HK1050318A1 (zh) 2003-06-20
DK1200115T3 (da) 2006-01-16
US7432360B2 (en) 2008-10-07
KR20020011143A (ko) 2002-02-07
JP2003517462A (ja) 2003-05-27
AU777397B2 (en) 2004-10-14
ES2248110T3 (es) 2006-03-16
ZA200200742B (en) 2003-06-25
AU7137400A (en) 2001-02-13
IL147755A (en) 2009-11-18
DE60022759T2 (de) 2006-06-22
EA200200073A1 (ru) 2002-08-29
CN1371284A (zh) 2002-09-25
HUP0202246A2 (en) 2002-10-28
PL202945B1 (pl) 2009-08-31
ATE304863T1 (de) 2005-10-15
PL353569A1 (en) 2003-12-01
NO20020303L (no) 2002-03-21
NO20020303D0 (no) 2002-01-21
KR100693263B1 (ko) 2007-03-13
EP1200115B1 (en) 2005-09-21
BR0012667A (pt) 2002-07-02
RS50355B (sr) 2009-11-10
CA2378945A1 (en) 2001-02-01
NZ516735A (en) 2004-01-30
EA006220B1 (ru) 2005-10-27
HRP20020159A2 (en) 2003-06-30
EE200200037A (et) 2003-04-15
EP1200115B9 (en) 2006-01-18
DE60022759D1 (de) 2006-02-02

Similar Documents

Publication Publication Date Title
MXPA00007404A (es) Composiciones de champu estilizantes.
DE69730202D1 (de) Azidfreie, gaserzeugende zusammensetzungen
WO2001034646A3 (en) Recombinant gelatins
AU2002215935A1 (en) Novel use of short-chained carboxylic acids
DK0895776T3 (da) Kosmetisk, lysskærmende præparat
ID23374A (id) Halogenopirimidin
AU3950099A (en) Hair styling compositions
ZA979284B (en) Styling shampoo compositions with improved styling polymer deposition.
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
AU3227700A (en) Skin sanitizing compositions
PL344475A1 (en) Bridged indenopyrrolocarbazoles
CA2392620A1 (en) Use of melatonin for the treatment of androgenetic and diffuse alopecia
ZA200200742B (en) Multi-dose erythropoietin formulations.
ATE207076T1 (de) Ara-c derivate
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
EP0983243A4 (en) NOVEL QUINOLINE- AND NAPHTHALENECARBOXAMIDES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INHIBITING CALPAIN
NO990498D0 (no) 19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon
IL139604A0 (en) Novel peptides
ATE241599T1 (de) 25-hydroxy-16-ene-26,27-bishome-cholecalcerifer l derivate
AU1252797A (en) Application of coatings to seeds, etc.
AU6832498A (en) Substituted benzyl oximino compounds
AP9901529A0 (en) Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them.
WO1999061598A3 (en) Lentiviral vector compositions and methods of use
HK1049485A1 (en) DithiepinoÄ6,5-BÜpyridines, and related compositions, methods of producing and uses.
FR2752699B1 (fr) Boitier, du type boitier de maquillage